Trident Lifeline Limited (BOM:543616)

Market Cap	2.98B -4.0%
Revenue (ttm)	1.27B +111.5%
Net Income	159.28M +57.7%
EPS	13.78 +57.0%
Shares Out	11.93M
PE Ratio	18.12
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	24,600
Average Volume	36,420
Open	249.95
Previous Close	253.15
Day's Range	247.10 - 250.90
52-Week Range	229.95 - 328.00
Beta	-0.27
RSI	47.62
Earnings Date	May 7, 2026

About Trident Lifeline

Trident Lifeline Limited, together with its subsidiaries, manufactures and markets finished doses in India, Ghana, Kenya, Peru, Cameroon, Venezuela, and internationally. The company offers various medicinal products, including pharmaceuticals, nutraceuticals, herbals, and injectables in the form of tablets, capsules, dry powders for oral suspension, oral liquids, ointments, liquid ointments, effervescent tablets, sachets, pastes, gels, solutions, suspensions, ice gels, syrups, and creams, as well as toothpaste and mouthwash. Its products target...

• Industry: Pharmaceutical Preparations
• Founded: 2014
• Employees: 74
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543616

Financial Performance

In fiscal year 2025, Trident Lifeline's revenue was 869.65 million, an increase of 94.86% compared to the previous year's 446.29 million. Earnings were 117.48 million, an increase of 85.18%.